Complete report $3,950. DataPack (test volumes, sales forecasts, supplier shares) $2,500.
This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot,
HTLV-I/II and other confirmatory tests performed in the following market segments:
- Commercial/Private Laboratories
- Blood Banks
- Public Health Laboratories
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
The report is based on a combination of primary and secondary information sources, including VPGMarketResearchs proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Contains 277 pages and 31 tables
SIMILAR MARKET STUDIES
2014-2018 US Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Forecasts, Emerging Technologies, Competitive Strategies. This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the ...
November 2014 | $7500 | View Details >>
This new 269-page report from Venture Planning Group provides a comprehensive analysis in the French endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.
December 2013 | $1500 | View Details >>
The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
November 1999 | $0 | View Details >>
This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including:
December 2013 | $2500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research